Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine-rich repeat-containing protein 52 (LRRC52) is a single-pass transmembrane auxiliary subunit belonging to the leucine-rich repeat family, primarily expressed in human testis and sperm. LRRC52 closely associates with Slo3 and BK potassium channels, dramatically shifting their gating properties and making them and their activity highly sensitive to pH and voltage changes. In sperm, LRRC52 is required for potassium current activation (KSper), making it essential for male fertility. It also regulates channel localization and stability in certain excitable cells. LRRC52's role is primarily functional modulation; there are currently no drugs directly targeting LRRC52, and loss of function is tied to infertility rather than any broader disease phenotype[1][2][3][5][7].
Alters the voltage dependence and gating characteristics of Slo3 and BK channels by acting as an auxiliary subunit. Stabilizes macromolecular complexes for proper localization of BK channels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine-rich repeat-containing protein 52 (LRRC52).